Scout | Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)

This grant opportunity aims to support projects that develop and conduct clinical trials for treatments, both drug-based and non-drug-based, addressing cognitive, behavioral, and neuropsychiatric issues linked with age-related cognitive decline, Alzheimer's disease, and related dementia. Additionally, it encourages research to improve trial design and methods.

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: July 1, 2024

Open for Submission: July 1, 2024

Submission Deadline: October 17, 2024

Application Window Closes: October 17, 2024

Keywords

Alzheimer's Disease

Clinical Trials

Dementia

Cognitive Decline

Pharmacological Interventions

Non-Pharmacological Interventions

Neuropsychiatric Changes

Trial Design

Behavioral Changes

Age-Related Diseases

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers